Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthetic route and preparation method of irbesartan

A compound and reaction technology, applied in the field of drug preparation, can solve the problems of long and tedious routes, safety risks and high costs, and achieve the effects of shortened reaction time, short reaction routes and high purity products

Active Publication Date: 2013-01-30
珠海保税区丽珠合成制药有限公司
View PDF8 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] This patent provides a new method for synthesizing irbesartan in order to solve the problems of high cost, long and cumbersome route and safety risks faced by the current method for preparing irbesartan

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic route and preparation method of irbesartan
  • Synthetic route and preparation method of irbesartan
  • Synthetic route and preparation method of irbesartan

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Add compound A (116g, 0.6mol) in a 5L three-necked flask, add 1200mL DCM, stir to dissolve, then weigh NaBrO 3 (180g, 1.20mol) dissolved in 600mLH 2 O, added to the above reaction system, stirred, and then weighed Na 2 S 2 o 4 (209g, 1.20mol) was dissolved in 1200mL of water, transferred to a constant pressure dropping funnel, and slowly added dropwise to the above solution. After the addition, the reaction was allowed to react at room temperature for 4h, and monitored by TLC until the reaction was complete. Sodium bisulfite solution was added dropwise at 25°C until the solution was pale yellow or colorless, and the layers were separated after standing. The aqueous phase was extracted with 400 mL of dichloromethane, and the organic phase was combined, washed twice with 800 mL of purified water, and the organic phase was vortexed. After drying, add ethyl acetate and n-hexane mixture, stir and crystallize, filter, and drain to obtain a white solid product, which is vac...

Embodiment 2

[0044] Add compound A (116g, 0.6mol) in a 5L three-necked flask, add 1200mL chlorobenzene, stir to dissolve, then weigh NaBrO 3 (180g, 1.20mol) was dissolved in 600mLH2O, added to the above reaction system, stirred, and then weighed Na 2 S 2 o 4 (209g, 1.20mol) was dissolved in 1200mL of water, transferred to a constant pressure dropping funnel, and slowly added dropwise to the above solution. After the addition, the reaction was allowed to react at room temperature for 4h, and monitored by TLC until the reaction was complete. Add sodium bisulfite solution dropwise at 250C until the solution is light yellow or colorless, let stand to separate layers, extract the aqueous phase with 400 mL of ethyl acetate, combine the organic phase, wash twice with 800 mL of purified water, and spin dry the organic phase , adding ethyl acetate and n-hexane mixture, stirring and crystallizing, filtering, and drying to obtain a white solid product, which was dried in vacuo at 400C for 2 hours, ...

Embodiment 3

[0046] Add compound C (46g, 0.2mol), compound B (54g, 0.2mol), dichloromethane 400mL, tetrabutylammonium bromide (0.7g, 0.002mol) into a 1L three-necked flask, stir and add sodium hydroxide (40g , 1mol) of 200mL aqueous solution, reacted at room temperature for 3h after the addition, and monitored by TLC until the reaction was completed. Stand to separate the layers, extract the aqueous phase with dichloromethane (100mL), combine the dichloromethane phases, wash twice with purified water, dry, spin dry the organic phase under reduced pressure, add ethyl acetate to dissolve, and then analyze with n-hexane. crystallized, filtered, collected the white solid product, and dried in vacuo at 40° C. for 2 h to obtain the product compound D (69.4 g), with a yield of 90% and a purity of 99% by HPLC.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a synthetic route and a preparation method of irbesartan. The method comprises three steps: (1) reacting a compound I (2-cyano-4'-methyl diphenyl), an inorganic salt oxidant, and an inorganic salt reductant in dichloromethane and water to form a compound IRB-02 (2-cyano-4'-bromomethylbiphenyl); (2) reacting a compound IRB-02, a compound IRB-01 (2-butyl-1, 3-diaza spiro [4.4] nonane-1-vinyl-4-ketone hydrochloride), tetrabutylammonium bromide and inorganic alkali in dichloromethane and water to obtain a compound IRB-03 (2-butyl-3-[(2-cyano biphenyl-4-base)methyl]-1,3-diaza spiro [4.4] nonane-1-vinyl-4-ketone); and (3) reacting a compound IRB-03, tetrabutylammonium bromide, zinc chloride and sodium azide in toluene to obtain the irbesartan.

Description

technical field [0001] The invention belongs to the technical field of medicine preparation methods, and in particular relates to a simple and efficient method for synthesizing irbesartan and its intermediates. Background technique [0002] Irbesartan is an angiotensin II (Angiotensin II, Ang II) receptor inhibitor, which can inhibit the transformation of Ang I into Ang II, and can specifically antagonize the angiotensin-converting enzyme 1 receptor (AT1). The antagonism is 500 times greater than that of AT28. It selectively blocks the combination of Ang II and AT1 receptors, inhibits vasoconstriction and release of aldosterone, and produces antihypertensive effects. It can be used for the treatment of hypertension, cardiovascular diseases of heart failure and prevention of disorders of the central nervous system, glaucoma, diabetic retinopathy and diabetic nephropathy. [0003] Irbesartan is a drug jointly developed by Bristol-Myers Squibb and France's Sanofi-Sindela Fort....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D403/10
Inventor 王建军江跃陈小恩肖鸿于迎春江晓漫
Owner 珠海保税区丽珠合成制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com